Clinical Impact of the Line Probe Assay and Xpert® MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial

Clinical Impact of the Line Probe Assay and Xpert® MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial

ABSTRACT Background: Rapid molecular methods such as the line probe assay (LPA) and Xpert® MTB/RIF assay (Xpert) have been recommended by the World Health Organization for drug-resistant tuberculosis (DR-TB) diagnosis. We conducted an interventional trial in DR-TB reference centers in Brazil to ev...

Full description

Bibliographic Details
Main Authors:	Afranio Kritski, Maria Martha Oliveira, Isabela Neves de Almeida, Daniela Ramalho, Monica Kramer de Noronha Andrade, Monica Carvalho, Pryscila Fernandes Campino Miranda, Margareth Pretti Dalcolmo, Jose Ueleres Braga, Tania Brígido, Eliene Mesquita, Claudia Dias, Aglae Gambirasio, Joao Baptista Souza Filho, Anne Detjen, Patrick Peter John Phillips, Ivor Langley, Paula Fujiwara, Stephen Bertel Squire
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2022-02-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Tuberculosis Diagnostics Impact assessment Molecular tests MDR-TB
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822022000100301&tlng=en

Similar Items

Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa
by: Ivor Langley, et al.
Published: (2015-02-01)

Utility of the Xpert MTB/RIF assay for diagnosis of tuberculous meningitis.
by: David R Boulware
Published: (2013-10-01)

Diagnosis of extrapulmonary TB: Experience with the Xpert MTB/Rif assay
by: C.N. Govind, et al.
Published: (2014-04-01)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
by: Metcalf, T, et al.
Published: (2018)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis.
by: Tatiana Metcalf, et al.
Published: (2018-01-01)

Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
by: Araya Gebreyesus Wasihun, et al.
Published: (2020-01-01)

A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town.
by: Pren Naidoo, et al.
Published: (2014-01-01)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis.
by: Nhu, N, et al.
Published: (2013)

Is GeneXpert MTB/RIF assay reliable for the diagnosis of pleural tuberculosis?
by: Muhammad Mudassir Shafiq, et al.
Published: (2022-06-01)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
by: Suraj Kumar, et al.
Published: (2017-04-01)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
by: Nhu Nguyen Thi Quynh, et al.
Published: (2013-01-01)

Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia.
by: Abebaw Kebede, et al.
Published: (2019-01-01)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
by: Raksha Rimal, et al.
Published: (2022-04-01)

Performance evaluation of Truenat MTB and Truenat MTB-RIF DX assays in comparison to gene XPERT MTB/RIF ultra for the diagnosis of pulmonary tuberculosis in Uganda
by: Willy Ssengooba, et al.
Published: (2024-02-01)

Rapid diagnosis of extra pulmonary tuberculosis by automated Xpert MTB/RIF assay
by: Suzana Shirly, et al.
Published: (2012-05-01)

Evaluation of Xpert MTB/RIF Assay, MTB Culture and Line Probe Assay for the Detection of MDR Tuberculosis in AFB Smear Negative Specimens
by: Chandri Lama, et al.
Published: (2022-10-01)

Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal
by: Priyatam Khadka, et al.
Published: (2019-12-01)

Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh
by: Samanta Biswas, et al.
Published: (2022-01-01)

Comparison of xpert MTB/RIF assay, line probe assay, and culture in diagnosis of pulmonary tuberculosis on bronchoscopic specimen
by: Swapna Kanade, et al.
Published: (2023-01-01)

Xpert MTB/RIF assay for the differential diagnosis between sarcoidosis and tuberculosis intrathoracic lymphadenopathy
by: Xian He, et al.
Published: (2023-10-01)

GeneXpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimens
by: Yu Pang, et al.
Published: (2017-07-01)

Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice.
by: Nakwon Kwak, et al.
Published: (2013-01-01)

Comparison of Interpretation between Pyrosequencing and Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis
by: Linda Choerunnisa, et al.
Published: (2020-12-01)

Diagnostic accuracy of GeneXpert MTB/RIF assay for detection of tubercular pleural effusion.
by: Jyoti Jain, et al.
Published: (2021-01-01)

Diagnostic accuracy of Xpert MTB/RIF assay for musculoskeletal tuberculosis: a meta-analysis
by: Wen H, et al.
Published: (2017-09-01)

The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study
by: Wakjira Kebede, et al.
Published: (2021-12-01)

The use of Gene-Xpert MTB RIF in the diagnosis of extrapulmonary tuberculosis in childhood and adolescence
by: Rafaela Baroni Aurilio, et al.
Published: (2020-10-01)

Cost-effectiveness of Xpert®MTB/RIF in the diagnosis of tuberculosis: pragmatic study
by: Suely Conceição Alves da Silva, et al.
Published: (2021-02-01)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
by: Diriba K, et al.
Published: (2021-09-01)

Advancing tuberculosis diagnosis and management in cynomolgus macaques using Xpert MTB/RIF ultra assay
by: Prapaporn Srilohasin, et al.
Published: (2024-01-01)

Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers
by: Nicole L. Rendell, et al.
Published: (2017-07-01)

Rifampicin Resistance by Xpert MTB/RIF Assay in Pulmonary Tuberculosis- Is there a Need for Confirmation by Retesting?
by: Swapna Rajesh Kanade, et al.
Published: (2022-05-01)

Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India
by: Rakesh Yadav, et al.
Published: (2020-01-01)

Xpert® MTB/RIF assay on formalin-fixed paraffin-embedded tissues in the diagnosis of extrapulmonary tuberculosis
by: Allan N. Njau, et al.
Published: (2019-09-01)

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
by: Kaican Zong, et al.
Published: (2019-08-01)

The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis.
by: Basant Joshi, et al.
Published: (2018-01-01)

Rapid molecular assay gene Xpert in detection of multi-drug resistant tuberculosis (MTB/Rif)
by: M. Habeeb, et al.
Published: (2020-12-01)

Diagnostic efficiency of Xpert MTB/RIF assay for osteoarticular tuberculosis in patients with inflammatory arthritis in China.
by: Yuan Li, et al.
Published: (2018-01-01)

Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosis: A meta-analysis.
by: Yanqin Shen, et al.
Published: (2019-01-01)

Application of CBNAAT (Xpert MTB/RIF assay) in new smear negative pulmonary tuberculosis patients
by: Vishal Chopra, et al.
Published: (2020-02-01)